Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease
- PMID: 22359526
- PMCID: PMC3282214
- DOI: 10.3345/kjp.2012.55.1.18
Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease
Abstract
Purpose: Transforming growth factor beta receptor 2 (TGFBR2) is a tumor suppressor gene that plays a role in the differentiation of striated cells and remodeling of coronary arteries. Single nucleotide polymorphisms (SNPs) of this gene are associated with Marfan syndrome and sudden death in patients with coronary artery disease. Cardiovascular remodeling and T cell activation of TGFBR2 gene suggest that the TGFBR2 gene SNPs are related to the pathogenesis of Kawasaki disease (KD) and coronary artery lesion (CAL).
Methods: The subjects were 105 patients with KD and 500 healthy adults as controls. Mean age of KD group was 32 months age and 26.6% of those had CAL. We selected TGFBR2 gene SNPs from serum and performed direct sequencing.
Results: The sequences of the eleven SNPs in the TGFBR2 gene were compared between the KD group and controls. Three SNPs (rs1495592, rs6550004, rs795430) were associated with development of KD (P=0.019, P=0.026, P=0.016, respectively). One SNP (rs1495592) was associated with CAL in KD group (P=0.022).
Conclusion: Eleven SNPs in TGFBR2 gene were identified at that time the genome wide association. But, with the change of the data base, only six SNPs remained associated with the TGFBR2 gene. One of the six SNPs (rs6550004) was associated with development of KD. One SNP associated with CAL (rs1495592) was disassociated from the TGFBR2 gene. The other five SNPs were not functionally identified, but these SNPs are notable because the data base is changing. Further studies involving larger group of patients with KD are needed.
Keywords: Coronary artery lesion; Genetic polymorphism; Kawasaki disease; Transforming growth factor-beta type II receptor.
Figures
Similar articles
-
[Association of single nucleotide polymorphism in TGFBR2 gene with Kawasaki disease and coronary artery lesions].Zhongguo Dang Dai Er Ke Za Zhi. 2013 Sep;15(9):767-70. Zhongguo Dang Dai Er Ke Za Zhi. 2013. PMID: 24034922 Chinese.
-
Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.Eur J Pediatr. 2016 May;175(5):705-13. doi: 10.1007/s00431-016-2696-8. Epub 2016 Feb 1. Eur J Pediatr. 2016. PMID: 26833052
-
Polymorphisms of methylenetetrahydrofolate reductase are not a risk factor for Kawasaki disease in the Korean population.Korean J Pediatr. 2011 Aug;54(8):335-9. doi: 10.3345/kjp.2011.54.8.335. Epub 2011 Aug 31. Korean J Pediatr. 2011. PMID: 22087200 Free PMC article.
-
Immunogenetics of Kawasaki disease.Clin Rev Allergy Immunol. 2020 Aug;59(1):122-139. doi: 10.1007/s12016-020-08783-9. Clin Rev Allergy Immunol. 2020. PMID: 32200494 Review.
-
Update of genetic susceptibility in patients with Kawasaki disease.Korean J Pediatr. 2015 Mar;58(3):84-8. doi: 10.3345/kjp.2015.58.3.84. Epub 2015 Mar 20. Korean J Pediatr. 2015. PMID: 25861330 Free PMC article. Review.
Cited by
-
CRISPR/Cas9-A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects.Int J Mol Sci. 2022 Sep 29;23(19):11482. doi: 10.3390/ijms231911482. Int J Mol Sci. 2022. PMID: 36232782 Free PMC article. Review.
-
A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease.PLoS One. 2015 Jul 6;10(7):e0132137. doi: 10.1371/journal.pone.0132137. eCollection 2015. PLoS One. 2015. PMID: 26146998 Free PMC article.
-
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.Comput Math Methods Med. 2013;2013:989307. doi: 10.1155/2013/989307. Epub 2013 Mar 6. Comput Math Methods Med. 2013. PMID: 23533546 Free PMC article. Review.
-
Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead.Front Pediatr. 2019 Jun 18;7:242. doi: 10.3389/fped.2019.00242. eCollection 2019. Front Pediatr. 2019. PMID: 31275907 Free PMC article. Review.
-
Insights Into Coronary Artery Lesions in Kawasaki Disease.Front Pediatr. 2020 Aug 25;8:493. doi: 10.3389/fped.2020.00493. eCollection 2020. Front Pediatr. 2020. PMID: 32984207 Free PMC article. Review.
References
-
- Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP US/Canadian Kawasaki Syndrome Study Group. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J. 1998;17:1144–1148. - PubMed
-
- Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001;90:40–44. - PubMed
-
- Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med. 2004;158:1166–1169. - PubMed
-
- Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, et al. Kawasaki disease in families. Pediatrics. 1989;84:666–669. - PubMed
LinkOut - more resources
Full Text Sources